Science watch

Our science watch section reports on the story behind the media-reported “breakthrough” headlines in dementia, by focusing on the original journal study. Reports of other developments in research on care and cure are also included.

09/09/2019		Axon Neuroscience announces positive results from Phase II ADAMANT trial of AADVac1, an anti-Tau immunotherapy
29/08/2019		Preclinical study shows links between dysfunctional calcium transport by mitochondria and Alzheimer’s disease
20/08/2019		Insight 46 study suggests that midlife hypertension may be linked to increased brain pathology and Alzheimer’s disease risk in older age
06/08/2019		Recent statistics show dementia is primary cause of death in England and Wales
05/08/2019		Alkahest announces top-line data from its Phase II clinical trial of GRF6019 in AD
04/08/2019		Eli Lilly, Apple and Evidation report their feasibility study on the use of smart devices to identify cognitive impairment
01/08/2019		AZTherapies completes enrolment in ALZT-OP1 Phase II trial for early AD
28/07/2019		Alzheimer’s Disease Neuroimaging Initiative study shows slower cognitive and clinical decline in participants with increased TREM2 in cerebrospinal fluid
24/07/2019		Luxembourg-born neuroscientist Michel Goedert awarded 2019 Royal Society Medal for his work on protein accumulation in AD
19/07/2019		Article in Science shows how amyloid beta induces brain capillary constriction, amplifying vascular dysfunction in AD
18/07/2019		Researchers report on high prevalence of apathy in AD
18/07/2019		International group of experts highlights the link between stroke and dementia, issuing call to action for joint prevention of both
17/07/2019		Eisai presents new data on BAN2401 and elenbecestat at AAIC
16/07/2019		AAIC launches press release on sex differences in AD
16/07/2019		Grifols presents additional results from its Phase IIb/III study in people with mild and moderate AD

 

Next » 1 2 3 4 5 ...111